Key Points
- Director Robert Mccabe, Jr. bought 890 shares of National Health Investors at an average price of $71.65, increasing his ownership by 2.06% to 44,159 shares.
- National Health Investors shares were down 1.9% to $70.73, and the stock has traded between a 52-week low of $67.94 and high of $91.38.
- The REIT reported Q1 earnings of $0.82 per share, missing analyst estimates, though revenue rose 28.9% year over year; it also declared a quarterly dividend of $0.92 per share, yielding about 5.2% annually.
National Health Investors, Inc. (NYSE:NHI - Get Free Report) Director Robert Mccabe, Jr. purchased 890 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average price of $71.65 per share, with a total value of $63,768.50. Following the purchase, the director directly owned 44,159 shares of the company's stock, valued at $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
National Health Investors Trading Down 1.9%
NYSE NHI opened at $70.73 on Tuesday. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The firm has a 50 day moving average of $77.04 and a two-hundred day moving average of $80.03. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $3.43 billion, a PE ratio of 22.82, a price-to-earnings-growth ratio of 3.87 and a beta of 0.52.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $1.21 by ($0.39). The firm had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. National Health Investors's revenue for the quarter was up 28.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.15 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts expect that National Health Investors, Inc. will post 4.93 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a $0.92 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.2%. National Health Investors's dividend payout ratio (DPR) is currently 118.71%.
Hedge Funds Weigh In On National Health Investors
Several hedge funds have recently made changes to their positions in the company. International Assets Investment Management LLC purchased a new stake in shares of National Health Investors in the 4th quarter valued at about $27,000. EverSource Wealth Advisors LLC grew its stake in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock worth $28,000 after buying an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC purchased a new position in National Health Investors during the 4th quarter worth approximately $33,000. GAMMA Investing LLC increased its position in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust's stock worth $35,000 after buying an additional 136 shares during the period. Finally, Key Capital Management INC acquired a new position in National Health Investors during the fourth quarter worth approximately $47,000. Hedge funds and other institutional investors own 62.51% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on NHI. Cantor Fitzgerald reiterated an "overweight" rating and issued a $94.00 price objective on shares of National Health Investors in a report on Wednesday, April 22nd. Truist Financial decreased their target price on National Health Investors from $89.00 to $81.00 and set a "buy" rating for the company in a research note on Friday. Weiss Ratings lowered shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research note on Friday. Wells Fargo & Company cut their price objective on shares of National Health Investors from $84.00 to $79.00 and set an "equal weight" rating on the stock in a report on Monday, June 1st. Finally, BMO Capital Markets reduced their price objective on shares of National Health Investors from $90.00 to $80.00 and set an "outperform" rating for the company in a research report on Monday. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, National Health Investors currently has a consensus rating of "Moderate Buy" and a consensus target price of $84.57.
Check Out Our Latest Stock Analysis on NHI
National Health Investors Company Profile
(
Get Free Report)
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
